Evolve Private Wealth LLC acquired a new stake in Agilent Technologies, Inc. (NYSE:A – Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 6,386 shares of the medical research company’s stock, valued at approximately $850,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Findlay Park Partners LLP purchased a new stake in shares of Agilent Technologies in the second quarter valued at approximately $174,281,000. Varma Mutual Pension Insurance Co purchased a new position in shares of Agilent Technologies during the 2nd quarter valued at approximately $11,340,000. Westpac Banking Corp acquired a new stake in Agilent Technologies in the 2nd quarter valued at $473,000. Sumitomo Life Insurance Co. acquired a new stake in Agilent Technologies in the 2nd quarter valued at $749,000. Finally, William Blair Investment Management LLC purchased a new stake in Agilent Technologies in the 2nd quarter worth $170,987,000.
Analyst Ratings Changes
A number of research firms have weighed in on A. HSBC reduced their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Wednesday, June 3rd. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Robert W. Baird boosted their price objective on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. TD Cowen increased their target price on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a report on Thursday, May 28th. Finally, Piper Sandler began coverage on Agilent Technologies in a research report on Thursday, June 11th. They issued a “neutral” rating and a $150.00 target price on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $160.24.
Agilent Technologies Stock Performance
NYSE:A opened at $159.25 on Monday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. The company’s 50-day moving average price is $137.57 and its 200-day moving average price is $126.17. Agilent Technologies, Inc. has a twelve month low of $108.35 and a twelve month high of $160.51. The company has a market cap of $44.98 billion, a P/E ratio of 31.98, a P/E/G ratio of 2.80 and a beta of 1.25.
Agilent Technologies (NYSE:A – Get Free Report) last issued its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, sell-side analysts forecast that Agilent Technologies, Inc. will post 6.05 earnings per share for the current fiscal year.
About Agilent Technologies
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
See Also
- Five stocks we like better than Agilent Technologies
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
